
Chembio Diagnostics CEMI
Annual report 2022
added 03-29-2023
Chembio Diagnostics Historical Prices 2011-2026 | CEMI
Annual Historical Prices Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.39 | 1.14 | 4.75 | 4.56 | 5.66 | 8.2 | 6.8 | 5.33 | 3.91 | 3.37 | 4.73 | 3.36 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.2 | 0.39 | 4.35 |
Historical Prices of other stocks in the Diagnostics research industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M | ||
|
BioNano Genomics
BNGO
|
1.46 | $ 1.13 | - | $ 6.15 M | ||
|
Burning Rock Biotech Limited
BNR
|
8.43 | $ 16.07 | -0.28 % | $ 173 M | ||
|
Agilent Technologies
A
|
139 | $ 115.27 | 0.17 % | $ 35 B | ||
|
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
0.74 | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
18.6 | $ 16.35 | 1.87 % | $ 871 M | ||
|
Akumin
AKU
|
0.84 | - | -17.87 % | $ 25.9 M | ||
|
Interpace Biosciences
IDXG
|
1.66 | $ 2.25 | -2.17 % | $ 9.95 M | ||
|
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
4.4 | $ 1.38 | 0.91 % | $ 1.84 M | ||
|
Exact Sciences Corporation
EXAS
|
103 | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
25.5 | $ 23.14 | 0.04 % | $ 643 M | ||
|
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
1.44 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
155 | $ 176.98 | 0.74 % | $ 8.77 B | ||
|
Medpace Holdings
MEDP
|
449 | $ 496.91 | 0.68 % | $ 14.3 B | ||
|
Danaher Corporation
DHR
|
210 | $ 191.04 | 0.78 % | $ 136 B | ||
|
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | ||
|
Myriad Genetics
MYGN
|
4.42 | $ 4.45 | 2.18 % | $ 412 M | ||
|
Illumina
ILMN
|
103 | $ 122.89 | 1.62 % | $ 19.5 B | ||
|
NeoGenomics
NEO
|
11.6 | $ 7.9 | 2.67 % | $ 1.01 B | ||
|
Fulgent Genetics
FLGT
|
15.4 | $ 14.96 | 3.64 % | $ 452 M | ||
|
Guardant Health
GH
|
107 | $ 79.03 | 0.54 % | $ 9.91 B | ||
|
QIAGEN N.V.
QGEN
|
38.3 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
3.19 | $ 2.76 | 2.6 % | $ 89.6 K | ||
|
Biomerica
BMRA
|
3.13 | $ 2.07 | -3.27 % | $ 4.75 M | ||
|
Invitae Corporation
NVTA
|
2.17 | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
32 | $ 28.14 | -0.58 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
201 | $ 107.18 | 0.35 % | $ 8.84 B | ||
|
Laboratory Corporation of America Holdings
LH
|
287 | $ 260.85 | -0.03 % | $ 21.7 B | ||
|
Natera
NTRA
|
53.9 | $ 197.77 | 2.46 % | $ 19.5 B | ||
|
Celcuity
CELC
|
115 | $ 118.02 | 0.75 % | $ 5.52 B | ||
|
Senseonics Holdings
SENS
|
8.4 | $ 6.61 | -1.05 % | $ 276 M | ||
|
Lantheus Holdings
LNTH
|
75.9 | $ 80.46 | -0.17 % | $ 5.43 B | ||
|
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | ||
|
Quest Diagnostics Incorporated
DGX
|
210 | $ 190.61 | -0.48 % | $ 21.2 B | ||
|
Soleno Therapeutics
SLNO
|
41 | $ 52.6 | -0.06 % | $ 2.67 B | ||
|
Neogen Corporation
NEOG
|
4.7 | $ 9.09 | -3.56 % | $ 1.97 B | ||
|
ENDRA Life Sciences
NDRA
|
4.65 | $ 5.0 | 1.21 % | $ 3.94 M | ||
|
Organovo Holdings
ONVO
|
2.12 | - | -2.3 % | $ 19.4 M |